Active Ingredient(s): Rufinamide
FDA Approved: * November 14, 2008
Pharm Company: * EISAI MEDCL RES
Category: Anticonvulsant

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome[2] and various other seizure disorders. Rufinamide, a triazole derivative, was developed in 2004 by Novartis Pharma, AG, and is manufactured by Eisai. Rufinamide was approved by the US Food and Drug Administration (FDA) on November 14, 2008, as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children four ye... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Banzel 262
Banzel 200 mg Oral Tablet
NDC: 62856-582
Eisai Inc.
Banzel E;263
Banzel 400 mg Oral Tablet
NDC: 62856-583
Eisai Inc.
Banzel 40 mg/ml Oral Suspension
NDC: 62856-584
Eisai Inc.
Banzel 40 mg/ml Oral Suspension
NDC: 68180-797
Lupin Pharmaceuticals, Inc.
Banzel 400 mg Oral Tablet, Film Coated
NDC: 75929-098
Pharma Packaging Solutions, LLC Dba Tjoapack LLC

Popular Topics

Anyone have experience with banzel?

My son is on banzel(along with 280ml of phenobarbital and1200 of keppra)for seizures. He's non verbal so he can'...